Skip to search formSkip to main contentSkip to account menu

Parathormone (human recombinant)

Known as: parathyroid hormone (1-84) human recombinant, rhPTH, rhPTH(1-84) 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Recombinant parathyroid hormone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Bone Biomechanics and Bone Quality: Effects of Pharmaceutical Agents Used to Treat Osteoporosis
The biomechanical properties of bone define skeletal fragility. Surrogates such as bone density or biochemical markers are used… 
Review
2013
Review
2013
Recombinant human parathyroid hormone therapy (1-34) in an adult patient with a gain-of-function mutation in the calcium-sensing receptor-a case report.
OBJECTIVE To describe a case of hypocalcemia in a patient with a gain-of-function mutation in the calcium-sensing receptor that… 
2013
2013
The rhPTH treatment elevates plasma secreted protein acidic and rich in cysteine levels in patients with osteoporosis
SummaryThe secreted protein acidic and rich in cysteine (SPARC), also known as osteonectin, plays an important role in osteoblast… 
2012
2012
The rhPTH (1-34), but not elcatonin, increases bone anabolic efficacy in postmenopausal women with osteoporosis.
PURPOSE Intermittent administration of recombinant human PTH [rhPTH (1-34)] exerts an osteoanabolic effect characterized by… 
2012
2012
Changes in serum runt-related transcription factor 2 levels after a 6-month treatment with recombinant human parathyroid hormone in patients with osteoporosis
Background: The mechanisms regulating the anabolic response of the skeleton for recombinant human PTH (1–34) [rhPTH (1–34… 
Highly Cited
2010
Highly Cited
2010
Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis
SummaryThe level of increased bone formation after 24 months of treatment with teriparatide (rhPTH (1–34), TPTD) is similar in… 
2009
2009
Safety, tolerability and pharmacokinetic study of recombinant human parathyroid hormone [rhPTH (1-84)] in Chinese healthy volunteers
SummaryThe current study was designed to determine the safety, tolerability and pharmacokinetic parameters of recombinant human… 
2008
2008
Effect of systemic intermittent administration of human parathyroid hormone (rhPTH[1-34]) on the resistance to reverse torque in rabbit tibiae.
The aim of this study was to evaluate the effect of intermittent administration of human parathyroid hormone [rhPTH (1-34)] on… 
2008
2008
Endogenous intact PTH is suppressed during Teriparatide (rhPTH 1-34) administration in postmenopausal women with established osteoporosis.
INTRODUCTION Teriparatide (recombinant human PTH 1-34/TPTD) is an osteoanabolic agent available for osteoporosis treatment. The… 
Highly Cited
2006
Highly Cited
2006
Impaired bone anabolic response to parathyroid hormone in Fgf2-/- and Fgf2+/- mice.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)